MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-01-0002836
Medirin Pharmaceuticals Private Limited - pharma in Ambala Cantt, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.42 Cr
▲ 1778% YoY
Net profit · FY 2025
₹2.6 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹45.79 Lakh
EBITDA margin 18.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹2.78 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
About Medirin Pharmaceuticals Private Limited
Data last updated:
Medirin Pharmaceuticals Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304HR2019PTC080556. Its GSTIN is 06AAMCM6958L1ZO (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sanjeev Aggarwal and Raman Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 6275/11 Nicholson Road, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.42 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.6 Lakh (net margin 1.1%) and EBITDA of ₹45.79 Lakh (EBITDA margin 18.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 64% over five years.
The company is associated with 1 brand: Medirin Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.78 Cr on record. Court records list 22 cases involving the company, including 22 filed by the company; 12 cases are pending.
Medirin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0002836). For more details, the company can be reached via its website medirin.com.
Company details
CIN U24304HR2019PTC080556
Registration Number 080556
Incorporation Date 27 May 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0002836
Recognitions & Rankings of Medirin Pharmaceuticals
Contact details
Medirin Pharmaceuticals Private Limited's registered office is in Ambala Cantt, Haryana. Its website is medirin.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address6275/11 Nicholson Road, Ambala Cantt, Haryana, India – 133001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medirin Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medirin Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medirin Pharmaceuticals operates one associated brand: Medirin Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and distribution of pharmaceutical products in India. | medirin.com |
Business activity
The main business activity of Medirin Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medirin Pharmaceuticals Private Limited, buy the company report.
Financials of Medirin Pharmaceuticals Private Limited
FY 2024 filings availableMedirin Pharmaceuticals Private Limited reported revenue of ₹2.42 Cr (up 1778% YoY) for FY 2025.
Revenue · FY 2025
₹2.42 Cr ▲ 1778%
Net profit · FY 2025
₹2.6 Lakh margin 1.1%
EBITDA · FY 2025
₹45.79 Lakh margin 18.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 19%
5 years · compounded
▲ 64%
EBITDA CAGR growth
3 years · compounded
▲ 144%
5 years · compounded
▲ 136%
Revenue has grown at a compounded annual rate (CAGR) of 64% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.9% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medirin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medirin Pharmaceuticals Private Limited
Medirin Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Aggarwal | Director | 20 Feb 2020 | 6 Years 8 Months | Current |
| Raman Aggarwal Also directs: Kanha Dreaminfra Private Limited, Divus Laboratories Limited | Director | 27 May 2019 | 7 Years 5 Months | Current |
| Pankaj Aggarwal | Director | 02 Feb 2024 | 2 Years 8 Months | Current |
| Tarun Dua Also directs: Casca Labs Private Limited, Kanha Dreaminfra Private Limited | Director | 02 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Medirin Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Render & Mech Formulations Private Limited | ₹2.43 Cr (FY 2024) | -21.0% | Chennai, Tamil Nadu, India | |||
| Olympus Lifesciences Private Limited | ₹2.43 Cr (FY 2024) | -29.0% | Kolkata, West Bengal, India | |||
| Grefuel Private Limited | ₹2.42 Cr (FY 2025) | 135.0% | Ankleshwar, Gujarat, India | |||
| Medirin Pharmaceuticals Private Limitedthis company | ₹2.42 Cr (FY 2025) | ₹2.6 Lakh | 1.1% | 1778.0% | Ambala Cantt, Haryana, India | |
| Medigold Life Sciences Private Limited | ₹2.41 Cr (FY 2021) | 705.0% | Uruli Kanchan, Maharashtra, India | |||
| Fourtrax Lifestyles Private Limited | ₹2.41 Cr (FY 2025) | 46.0% | Karnal, Haryana, India |
To see the full peer comparison of Medirin Pharmaceuticals Private Limited, buy the company report.
Auditor
Medirin Pharmaceuticals Private Limited is audited by AJAY MITTAL AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY MITTAL AND COMPANY | FY 2023 | 04770N |
Shareholding
The shareholding of Medirin Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Medirin Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.78 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2021 | 100478893 | Hdfc Bank Limited | ₹2.78 Cr | Open |
To see the full charge records of Medirin Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Medirin Pharmaceuticals Private Limited has 22 court cases on record: 22 filed by Medirin Pharmaceuticals. 12 cases are pending and 10 are disposed.
Total cases
22
Filed by the company
22
Pending
12
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 0 | 12 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S A. S. Pharmaceuticals | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S Aarav Pharma | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S Amit Medical Agency | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S Ziya Healthcare THR. Prop. Mr. Usman and 1 other | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S Ramesh Medical Store | Pending |
To see the full case history of Medirin Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medirin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medirin Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAMCM6958L1ZO | Haryana | Active | 13 Jun 2019 |
To see the full GST registrations and return filing status of Medirin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medirin Pharmaceuticals Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Pankaj Aggarwal was appointed as Director on 02 Feb 2024.
AGM
Medirin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Medirin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Pankaj Aggarwal was appointed as Director.
Appointed
Tarun Dua was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 278.35 Lakh registered on 29 Jun 2021 with Charge ID 100478893 was modified on 04 Oct 2023.
Ceased
Jatinder Pal Singh ceased to be Director.
Ceased
Parvinder Pal Singh Dhillon ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 278.35 Lakh with Charge ID 100478893 was registered on 29 Jun 2021.
Appointed
Sanjeev Aggarwal was appointed as Director.
Appointed
Raman Aggarwal was appointed as Director.
Incorporation
27 May 2019
Medirin Pharmaceuticals Private Limited was registered on 27 May 2019 with Roc Delhi & aged 7 years 5 months as per MCA records.
Frequently asked questions
Medirin Pharmaceuticals is an active private limited company based in Ambala Cantt, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 May 2019 (7+ years old) and is registered under CIN U24304HR2019PTC080556.
Medirin Pharmaceuticals has 4 current directors:
- Sanjeev Aggarwal - Director
- Raman Aggarwal - Director
- Pankaj Aggarwal - Director
- Tarun Dua - Director
The latest financial statements of Medirin Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Medirin Pharmaceuticals is 06AAMCM6958L1ZO, registered in Haryana.
The CIN (Corporate Identification Number) of Medirin Pharmaceuticals is U24304HR2019PTC080556. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medirin Pharmaceuticals has 22 court cases on record: 22 filed by the company. 12 are pending.
Medirin Pharmaceuticals was incorporated on 27 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medirin Pharmaceuticals by revenue are Render & Mech Formulations Private Limited, Olympus Lifesciences Private Limited, Grefuel Private Limited, Medigold Life Sciences Private Limited, Fourtrax Lifestyles Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pankaj Aggarwal was appointed as Director on 02 Feb 2024. Tarun Dua was appointed as Director on 02 Feb 2024. Jatinder Pal Singh ceased to be Director on 28 Mar 2023. Medirin Pharmaceuticals has 6 board changes on record in total.
Yes, Medirin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0002836).
Medirin Pharmaceuticals can be reached through the website medirin.com. Its registered office is in Ambala Cantt, Haryana, India.